Evaluation of Fibronectin, Vitronectin, and Leptin Levels in Coronary Artery Disease: Impacts on Thrombosis and Thrombolysis

Evaluation of Fibronectin, Vitronectin, and Leptin Levels in Coronary Artery Disease: Impacts on Thrombosis and Thrombolysis

In this study, the levels of fibronectin, vitronectin, leptin, tissue plasminogen activator (t-PA), and lipid parameters were investigated in patients with coronary artery disease (CAD) and control group. The average plasma fibronectin levels in CAD patients group were significantly higher compared...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and applied thrombosis/hemostasis 2005-01, Vol.11 (1), p.63-70
Hauptverfasser: Ekmekci, Hakan, Ekmekci, Ozlem B., Sonmez, Huseyin, Ozturk, Zeynep, Domanic, Nergiz, Kokoglu, Emine
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Body Mass Index
Cardiovascular disease
Cholesterol - blood
Coronary Disease - blood
Coronary vessels
Early intervention
Female
Fibronectins - blood
Humans
Hypertension - blood
Leptin - blood
Male
Middle Aged
Plasma
Smoking
Thrombosis - blood
Tissue Plasminogen Activator - blood
Vitronectin - blood
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this study, the levels of fibronectin, vitronectin, leptin, tissue plasminogen activator (t-PA), and lipid parameters were investigated in patients with coronary artery disease (CAD) and control group. The average plasma fibronectin levels in CAD patients group were significantly higher compared with the control group (p=0.006). Moreover, in patients with triple-vessel disease, plasma fibronectin levels were found to be significantly higher than those in the control group (p
ISSN:1076-0296
1938-2723
DOI:10.1177/107602960501100107